Moneycontrol PRO
Loans
Loans
X

business

Stocks To Watch: Alembic Pharma, BHEL, Zydus Life, Wipro In Focus | February 17

In today's stock market update for February 17, we highlight key stocks to watch: Wipro, which appointed Amit Kumar as Managing Partner and Global Head of Consulting; BHEL, which secured a Letter of Intent for a thermal power project; and Alembic Pharma, which received a Voluntary Action Indicated classification from the US FDA for its Jarod facility. Zydus Lifesciences passed a successful US FDA inspection with no observations at its Ambernath site. Meanwhile, Ujjivan Small Finance Bank and Shriram Finance face RBI penalties for non-compliance with loan and KYC regulations. Stay tuned for more market insights!

first published: Feb 17, 2025 09:30 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347